Skip to content

Application of tranexamic acid enhanced recovery after correction surgery for spinal deformity to reduce postoperative hemorrhage: a prospective randomized controlled trial

Application of tranexamic acid enhanced recovery after correction surgery for spinal deformity to reduce postoperative hemorrhage: a prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017565
Enrollment
Unknown
Registered
2018-08-04
Start date
2018-08-06
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Idiopathic Scoliosis

Interventions

A:2g intravenous TXA intraoperatively, and 0.5g intravenous TXA 6h 12h 18h postoperatively
B:2g intravenous TXA intraoperatively, and 1g oral TXA 4h, 10h, and 16h postoperatively
C:2g intravenous TXA intraoperatively

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 22 Years

Inclusion criteria

Inclusion criteria: 1. Patients following PSF due to AIS; 2. Patients with preoperative platelet and coagulation function dysfunction; 3. Voluntarily participated in clinical trials and signed informed consent, good compliance of patients.

Exclusion criteria

Exclusion criteria: 1. Patients with history of venous thromboembolism, pulmonary embolism, cerebral infarction, coronary heart disease; 2. Patients with coagulation disorders; 3. Anticoagulant drugs are being used; 4. Administration of NSAID for less than 1 weeks; 5. TXA allergy; 6. Severe liver and renal insufficiency.

Design outcomes

Primary

MeasureTime frame
Total blood loss;Hidden blood loss;

Secondary

MeasureTime frame
Hb level;Hct;Hb drop;Hct drop;Intraoperative blood loss;Wound complications;Other adverse events;D-Dimer;Fibrin degradation products;Postoperative hospital stay ;Allogeneic blood transfusion rate;

Countries

China

Contacts

Public ContactYueming Song

West China Hospital, Sichuan University

hx_sym@163.com+86 18980601382

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026